Immix Biopharma, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q2 2022 to Q2 2025
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Immix Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2022 to Q2 2025.
- Immix Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 30M shares, a 4.16% increase year-over-year.
- Immix Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 28.3M shares, a 63.1% increase from 2023.
- Immix Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 17.3M shares, a 24.9% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)